-diphospho-glucuronosyl transferases (UGTs) UGT1A9 and UGT2B7, which are responsible for approximately 55% of tapentadol metabolism in humans.41 The major metabolite of tapentadol, tapentadol-O-glucuronide, has no activity at opioid receptors, synaptosomal reuptake systems, or other binding sites.35 Morphine is likewise primarily metabolized by hepatic glucuronidation via UGT2B7 to morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G).42 Morphine-3-glucuronide has no analgesic activity, but M6G has an affinity for the ?
|